229 related articles for article (PubMed ID: 34464235)
1. Integrated Biomarkers for the Management of Indeterminate Pulmonary Nodules.
Kammer MN; Lakhani DA; Balar AB; Antic SL; Kussrow AK; Webster RL; Mahapatra S; Barad U; Shah C; Atwater T; Diergaarde B; Qian J; Kaizer A; New M; Hirsch E; Feser WJ; Strong J; Rioth M; Miller YE; Balagurunathan Y; Rowe DJ; Helmey S; Chen SC; Bauza J; Deppen SA; Sandler K; Maldonado F; Spira A; Billatos E; Schabath MB; Gillies RJ; Wilson DO; Walker RC; Landman B; Chen H; Grogan EL; Barón AE; Bornhop DJ; Massion PP
Am J Respir Crit Care Med; 2021 Dec; 204(11):1306-1316. PubMed ID: 34464235
[No Abstract] [Full Text] [Related]
2. Improving lung cancer diagnosis with cancer, fungal, and imaging biomarkers.
Marmor HN; Kammer MN; Deppen SA; Shipe M; Welty VF; Patel K; Godfrey C; Billatos E; Herman JG; Wilson DO; Kussrow AK; Bornhop DJ; Maldonado F; Chen H; Grogan EL
J Thorac Cardiovasc Surg; 2023 Sep; 166(3):669-678.e4. PubMed ID: 36792410
[TBL] [Abstract][Full Text] [Related]
3. Improving malignancy risk prediction of indeterminate pulmonary nodules with imaging features and biomarkers.
Marmor HN; Jackson L; Gawel S; Kammer M; Massion PP; Grogan EL; Davis GJ; Deppen SA
Clin Chim Acta; 2022 Sep; 534():106-114. PubMed ID: 35870539
[TBL] [Abstract][Full Text] [Related]
4. Assessing the Accuracy of a Deep Learning Method to Risk Stratify Indeterminate Pulmonary Nodules.
Massion PP; Antic S; Ather S; Arteta C; Brabec J; Chen H; Declerck J; Dufek D; Hickes W; Kadir T; Kunst J; Landman BA; Munden RF; Novotny P; Peschl H; Pickup LC; Santos C; Smith GT; Talwar A; Gleeson F
Am J Respir Crit Care Med; 2020 Jul; 202(2):241-249. PubMed ID: 32326730
[No Abstract] [Full Text] [Related]
5. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules.
Daly S; Rinewalt D; Fhied C; Basu S; Mahon B; Liptay MJ; Hong E; Chmielewski G; Yoder MA; Shah PN; Edell ES; Maldonado F; Bungum AO; Borgia JA
J Thorac Oncol; 2013 Jan; 8(1):31-6. PubMed ID: 23201823
[TBL] [Abstract][Full Text] [Related]
6. An integrated risk predictor for pulmonary nodules.
Kearney P; Hunsucker SW; Li XJ; Porter A; Springmeyer S; Mazzone P
PLoS One; 2017; 12(5):e0177635. PubMed ID: 28545097
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
[TBL] [Abstract][Full Text] [Related]
8. Preoperative diagnosis of malignant pulmonary nodules in lung cancer screening with a radiomics nomogram.
Liu A; Wang Z; Yang Y; Wang J; Dai X; Wang L; Lu Y; Xue F
Cancer Commun (Lond); 2020 Jan; 40(1):16-24. PubMed ID: 32125097
[TBL] [Abstract][Full Text] [Related]
9. Indeterminate Pulmonary Nodules in Colorectal Cancer: Follow-up Guidelines Based on a Risk Predictive Model.
Kim CH; Huh JW; Kim HR; Kim YJ
Ann Surg; 2015 Jun; 261(6):1145-52. PubMed ID: 25119121
[TBL] [Abstract][Full Text] [Related]
10. Accurate diagnosis of pulmonary nodules using a noninvasive DNA methylation test.
Liang W; Chen Z; Li C; Liu J; Tao J; Liu X; Zhao D; Yin W; Chen H; Cheng C; Yu F; Zhang C; Liu L; Tian H; Cai K; Liu X; Wang Z; Xu N; Dong Q; Chen L; Yang Y; Zhi X; Li H; Tu X; Cai X; Jiang Z; Ji H; Mo L; Wang J; Fan JB; He J
J Clin Invest; 2021 May; 131(10):. PubMed ID: 33793424
[TBL] [Abstract][Full Text] [Related]
11. Radiomic signature based on CT imaging to distinguish invasive adenocarcinoma from minimally invasive adenocarcinoma in pure ground-glass nodules with pleural contact.
Jiang Y; Che S; Ma S; Liu X; Guo Y; Liu A; Li G; Li Z
Cancer Imaging; 2021 Jan; 21(1):1. PubMed ID: 33407884
[TBL] [Abstract][Full Text] [Related]
12. Reducing uncertainty in cancer risk estimation for patients with indeterminate pulmonary nodules using an integrated deep learning model.
Gao R; Li T; Tang Y; Xu K; Khan M; Kammer M; Antic SL; Deppen S; Huo Y; Lasko TA; Sandler KL; Maldonado F; Landman BA
Comput Biol Med; 2022 Nov; 150():106113. PubMed ID: 36198225
[TBL] [Abstract][Full Text] [Related]
13. Pathologic categorization of lung nodules: Radiomic descriptors of CT attenuation distribution patterns of solid and subsolid nodules in low-dose CT.
Zhou C; Chan HP; Chughtai A; Hadjiiski LM; Kazerooni EA; Wei J
Eur J Radiol; 2020 Aug; 129():109106. PubMed ID: 32526671
[TBL] [Abstract][Full Text] [Related]
14. A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules.
Xing W; Sun H; Yan C; Zhao C; Wang D; Li M; Ma J
BMC Cancer; 2021 Mar; 21(1):263. PubMed ID: 33691657
[TBL] [Abstract][Full Text] [Related]
15. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
Li X; Zhang Q; Jin X; Cao L
World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
[TBL] [Abstract][Full Text] [Related]
16. Radiomics for lung adenocarcinoma manifesting as pure ground-glass nodules: invasive prediction.
Sun Y; Li C; Jin L; Gao P; Zhao W; Ma W; Tan M; Wu W; Duan S; Shan Y; Li M
Eur Radiol; 2020 Jul; 30(7):3650-3659. PubMed ID: 32162003
[TBL] [Abstract][Full Text] [Related]
17. Preoperative CT-based radiomics combined with intraoperative frozen section is predictive of invasive adenocarcinoma in pulmonary nodules: a multicenter study.
Wu G; Woodruff HC; Sanduleanu S; Refaee T; Jochems A; Leijenaar R; Gietema H; Shen J; Wang R; Xiong J; Bian J; Wu J; Lambin P
Eur Radiol; 2020 May; 30(5):2680-2691. PubMed ID: 32006165
[TBL] [Abstract][Full Text] [Related]
18. The Probability of Lung Cancer in Patients With Incidentally Detected Pulmonary Nodules: Clinical Characteristics and Accuracy of Prediction Models.
Vachani A; Zheng C; Amy Liu IL; Huang BZ; Osuji TA; Gould MK
Chest; 2022 Feb; 161(2):562-571. PubMed ID: 34364866
[TBL] [Abstract][Full Text] [Related]
19. Combination of positron emission tomography/computed tomography and chest thin-layer high-resolution computed tomography for evaluation of pulmonary nodules: Correlation with imaging features, maximum standardized uptake value, and pathology.
Hou S; Lin X; Wang S; Shen Y; Meng Z; Jia Q; Tan J
Medicine (Baltimore); 2018 Aug; 97(31):e11640. PubMed ID: 30075545
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules.
Maiga AW; Deppen SA; Mercaldo SF; Blume JD; Montgomery C; Vaszar LT; Williamson C; Isbell JM; Rickman OB; Pinkerman R; Lambright ES; Nesbitt JC; Grogan EL
JAMA Surg; 2018 Apr; 153(4):329-334. PubMed ID: 29117314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
